Literature DB >> 16416231

Relapse of inflammatory bowel disease associated with use of nonsteroidal anti-inflammatory drugs.

Angela M Meyer1, Nizar N Ramzan, Russell I Heigh, Jonathan A Leighton.   

Abstract

To determine whether an association exists between relapse in inflammatory bowel disease and use of nonsteroidal anti-inflammatory drugs (NSAIDs), a retrospective records review was conducted of patients with Crohn's disease, ulcerative colitis, or indeterminate colitis examined at an outpatient tertiary care center between July 17, 2000, and November 1, 2001. Extracted data collected during the patient's last visit included medication use, maintenance therapy, disease activity, and smoking status. Use of NSAIDs was defined as a daily dose or more of any type the month before relapse. Of 60 patients (22, relapse; 38, remission), 9 (41%) in relapse and 10 (26%) in remission used NSAIDs. Maintenance therapy varied from 68% (relapse) to 92% (remission). The adjusted odds ratio between medication use and relapse was 6.31 (95% confidence interval, 1.16-34.38; P = .03). Use of NSAIDs was associated with relapse. A prospective cohort study that corrects for maintenance therapy is needed to evaluate this relationship.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16416231     DOI: 10.1007/s10620-006-3103-5

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  31 in total

1.  Effects of nonsteroidal antiinflammatory drugs on inflammatory bowel disease: a case-control study.

Authors:  J B Felder; B I Korelitz; R Rajapakse; S Schwarz; A P Horatagis; G Gleim
Journal:  Am J Gastroenterol       Date:  2000-08       Impact factor: 10.864

2.  Neuronal COX-2 expression in human myenteric plexus in active inflammatory bowel disease.

Authors:  P J Roberts; K Morgan; R Miller; J O Hunter; S J Middleton
Journal:  Gut       Date:  2001-04       Impact factor: 23.059

3.  Exacerbation of inflammation-associated colonic injury in rat through inhibition of cyclooxygenase-2.

Authors:  B K Reuter; S Asfaha; A Buret; K A Sharkey; J L Wallace
Journal:  J Clin Invest       Date:  1996-11-01       Impact factor: 14.808

4.  Safety of selective cyclooxygenase-2 inhibitors in inflammatory bowel disease.

Authors:  Uma Mahadevan; Edward V Loftus; William J Tremaine; William J Sandborn
Journal:  Am J Gastroenterol       Date:  2002-04       Impact factor: 10.864

5.  Proctocolitis induced by salicylate.

Authors:  D Rutherford; G Stockdill; D W Hamer-Hodges; A Ferguson
Journal:  Br Med J (Clin Res Ed)       Date:  1984-03-10

Review 6.  Cyclooxygenase in biology and disease.

Authors:  R N Dubois; S B Abramson; L Crofford; R A Gupta; L S Simon; L B Van De Putte; P E Lipsky
Journal:  FASEB J       Date:  1998-09       Impact factor: 5.191

7.  Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis.

Authors:  T D Warner; F Giuliano; I Vojnovic; A Bukasa; J A Mitchell; J R Vane
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-22       Impact factor: 11.205

Review 8.  Selective inhibitors of cyclooxygenase-2: are they really effective, selective, and GI-safe?

Authors:  J L Wallace; B K Reuter; W McKnight; A Bak
Journal:  J Clin Gastroenterol       Date:  1998       Impact factor: 3.062

Review 9.  Nonsteroidal anti-inflammatory drug-associated toxicity of the liver, lower gastrointestinal tract, and esophagus.

Authors:  D Bjorkman
Journal:  Am J Med       Date:  1998-11-02       Impact factor: 4.965

10.  Cyclooxygenase 2 is induced in colonic epithelial cells in inflammatory bowel disease.

Authors:  I I Singer; D W Kawka; S Schloemann; T Tessner; T Riehl; W F Stenson
Journal:  Gastroenterology       Date:  1998-08       Impact factor: 22.682

View more
  24 in total

1.  Role of Nonsteroidal Anti-Inflammatory Drugs in Exacerbations of Inflammatory Bowel Disease.

Authors:  Millie D Long; Michael D Kappelman; Christopher F Martin; Wenli Chen; Kristen Anton; Robert S Sandler
Journal:  J Clin Gastroenterol       Date:  2016-02       Impact factor: 3.062

Review 2.  Recent advances in understanding ulcerative colitis.

Authors:  Antonio Di Sabatino; Paolo Biancheri; Laura Rovedatti; Thomas Thornton Macdonald; Gino Roberto Corazza
Journal:  Intern Emerg Med       Date:  2011-11-09       Impact factor: 3.397

3.  Systematic review with meta-analysis: association between acetaminophen and nonsteroidal anti-inflammatory drugs (NSAIDs) and risk of Crohn's disease and ulcerative colitis exacerbation.

Authors:  O O Moninuola; W Milligan; P Lochhead; H Khalili
Journal:  Aliment Pharmacol Ther       Date:  2018-04-05       Impact factor: 8.171

Review 4.  Do non-steroidal anti-inflammatory drugs cause exacerbations of inflammatory bowel disease?

Authors:  Linda A Feagins; Byron L Cryer
Journal:  Dig Dis Sci       Date:  2010-02       Impact factor: 3.199

Review 5.  Environmental factors in the relapse and recurrence of inflammatory bowel disease: a review of the literature.

Authors:  Thomas D Martin; Simon S M Chan; Andrew R Hart
Journal:  Dig Dis Sci       Date:  2014-11-19       Impact factor: 3.199

6.  Challenges in the Diagnosis and Management of Inflammatory Bowel Disease in the Elderly.

Authors:  Sasha Taleban
Journal:  Curr Treat Options Gastroenterol       Date:  2015-09

7.  Environmental influences on the onset and clinical course of Crohn's disease-part 2: infections and medication use.

Authors:  Adam M Berg; Aamir N Dam; Francis A Farraye
Journal:  Gastroenterol Hepatol (N Y)       Date:  2013-12

8.  Anti-inflammatory pharmacotherapy with ketoprofen ameliorates experimental lymphatic vascular insufficiency in mice.

Authors:  Kenta Nakamura; Kavita Radhakrishnan; Yat Man Wong; Stanley G Rockson
Journal:  PLoS One       Date:  2009-12-21       Impact factor: 3.240

Review 9.  Environmental risk factors for inflammatory bowel diseases: Evidence based literature review.

Authors:  Ayokunle T Abegunde; Bashir H Muhammad; Owais Bhatti; Tauseef Ali
Journal:  World J Gastroenterol       Date:  2016-07-21       Impact factor: 5.742

Review 10.  Exacerbation of inflammatory bowel diseases associated with the use of nonsteroidal anti-inflammatory drugs: myth or reality?

Authors:  Helenie Kefalakes; Theodoros J Stylianides; George Amanakis; George Kolios
Journal:  Eur J Clin Pharmacol       Date:  2009-08-27       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.